We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 26th:
SS&C Technologies Holdings, Inc. (SSNC - Free Report) : This software products and software-enabled services provider to financial services providers, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
SS&C Technologies Holdings, Inc. Price and Consensus
Molina Healthcare, Inc. (MOH - Free Report) : This Medicaid-related solutions provider, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.6% over the last 60 days.
The Estée Lauder Companies Inc. (EL - Free Report) : This manufacturer of consumer products such as skin care, hair care, fragrance and makeup etc, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.
The Estee Lauder Companies Inc. Price and Consensus
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Growth Stocks to Buy for February 26th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 26th:
SS&C Technologies Holdings, Inc. (SSNC - Free Report) : This software products and software-enabled services provider to financial services providers, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
SS&C Technologies Holdings, Inc. Price and Consensus
SS&C Technologies Holdings, Inc. price-consensus-chart | SS&C Technologies Holdings, Inc. Quote
SS&C has a PEG ratio of 1.16, compared with 3.68 for the industry. The company possesses a Growth Score of B.
SS&C Technologies Holdings, Inc. PEG Ratio (TTM)
SS&C Technologies Holdings, Inc. peg-ratio-ttm | SS&C Technologies Holdings, Inc. Quote
Molina Healthcare, Inc. (MOH - Free Report) : This Medicaid-related solutions provider, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.6% over the last 60 days.
Molina Healthcare, Inc Price and Consensus
Molina Healthcare, Inc price-consensus-chart | Molina Healthcare, Inc Quote
Molina has a PEG ratio of 1.16, compared with 3.48 for the industry. The company possesses a Growth Score of B.
Molina Healthcare, Inc PEG Ratio (TTM)
Molina Healthcare, Inc peg-ratio-ttm | Molina Healthcare, Inc Quote
The Estée Lauder Companies Inc. (EL - Free Report) : This manufacturer of consumer products such as skin care, hair care, fragrance and makeup etc, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.
The Estee Lauder Companies Inc. Price and Consensus
The Estee Lauder Companies Inc. price-consensus-chart | The Estee Lauder Companies Inc. Quote
Estée Lauder has a PEG ratio of 2.55, compared with 2.92 for the industry. The company possesses a Growth Score of B.
The Estee Lauder Companies Inc. PEG Ratio (TTM)
The Estee Lauder Companies Inc. peg-ratio-ttm | The Estee Lauder Companies Inc. Quote
See the full list of top ranked stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>